ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1119

Association of Primary Insurance Status on Bilateral Knee Arthroplasty Utilization and Complications: A United States Nationwide Analysis

Bella Mehta1, Kaylee Ho2, Jennifer Bido3, Stavros Memtsoudis3, Michael Parks4, Linda Russell5, Susan Goodman1 and Said Ibrahim6, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Weill Cornell Medicine, New York, 3Hospital for Special Surgery, New York, 4Hospital for Special Surgery, Weill Cornell Medicine, New York, 5Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 6Weill Cornell Medicine, Cleveland, OH

Meeting: ACR Convergence 2020

Keywords: Arthroplasty, Disparities, Osteoarthritis, Outcome measures, Total joint replacement

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: In patients with end-stage bilateral knee osteoarthritis, treatment options include either a staged total knee arthroplasty (TKA) procedure, often with a few months in between surgeries, or a simultaneous bilateral TKA (BTKA) procedure during the same anesthetic session. The choice in treatment strategy largely depends on patient and surgeon preferences, and guidelines vary per institution. Our objective was to assess if variations in utilization and in-hospital complications in BTKA are associated with primary insurance.

Methods: Using the National Inpatient Sample (NIS)- Healthcare Cost and Utilization Project (HCUP) database (2007-2016) we sought to examine BTKA utilization and in-hospital complications comparing those with Medicare/Medicaid (CMS) vs those with private insurance (Pvt) in a retrospective analysis. All patients ≥ 50 years who underwent elective primary TKA were included. We computed differences in temporal trends in proportional utilization and in-hospital complications after BTKA comparing those with CMS vs Pvt insurance. Next, we performed multivariable logistic regression models to assess insurance differences in temporal trends adjusting for individual (age, sex, Elixhauser comorbidity index, and morbid obesity), hospital level (hospital volume, bed size, region and teaching status) and community level (median household income) variables. Discharge weights were used for nationwide estimates.

Results: An estimated 132,400 (49.5%) CMS patients and 135,046 (50.5%) privately insured patients underwent BTKA from 2007-2016. (Table 1) Amongst UTKA patients, 62.7% had CMS insurance and 37.3% had Pvt. While in both UTKA and BTKA, patients with private insurance were more likely to be younger and had a higher proportion of females. In univariate analysis, hospital mortality, length of stay and complications were significantly higher in those with CMS compared to private insurance (p < 0.001). After adjusting for covariates, CMS was associated with higher odds of in-hospital BTKA and UTKA complications compared to Pvt (Bilateral aOR: 1.10, 95% CI: 1.05–1.15, P = < 0.0001; Unilateral aOR: 1.32, 95% CI: 1.10–1.59, P = 0.003). BTKA in-hospital complications remained higher in CMS group throughout the study period (1.23% in Pvt vs 1.36% in CMS in 2007-08, whereas 0.54% in Pvt vs 1.14% in CMS in 2015-16), though the trend difference was not statistically significant (Figure 1). Proportional utilization of BTKA amongst private insurance was higher than CMS throughout the study period even after adjusting for covariates (7.18% in Pvt vs 4.59% in CMS in 2007-08, whereas 5.63% in Pvt vs 3.13% in CMS in 2015-16, P < .0001) (Figure 2).

Conclusion: In this nationwide study of BTKA patients from 2007 to 2016, we found that the utilization of BTKA is higher in those who are privately insured compared to those who have Medicare/Medicare insurance. Further privately insured patients have lower in-hospital complication rates compared to those with government insurance. There can be many factors explaining these findings such as working status and patient preference which may play a role in BTKA decisions and thus further research in this area need to be done to understand these differences.

Table1: Baseline characteristics and outcomes by TKA type and Insurance

Figure 1: Bilateral Complications by Primary Insurance

Figure 2: Percentage of Bilateral TKAs by Primary Insurance


Disclosure: B. Mehta, Novartis, 1; K. Ho, None; J. Bido, None; S. Memtsoudis, Teikoku, 1, Sandoz Inco, 1, HATH, 1; M. Parks, ZimmerBiomet, 1; L. Russell, None; S. Goodman, Pfizer, 1, Novartis, 1, UCB, 1, regenosine, 1, 2, Horizon, 1; S. Ibrahim, None.

To cite this abstract in AMA style:

Mehta B, Ho K, Bido J, Memtsoudis S, Parks M, Russell L, Goodman S, Ibrahim S. Association of Primary Insurance Status on Bilateral Knee Arthroplasty Utilization and Complications: A United States Nationwide Analysis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/association-of-primary-insurance-status-on-bilateral-knee-arthroplasty-utilization-and-complications-a-united-states-nationwide-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-primary-insurance-status-on-bilateral-knee-arthroplasty-utilization-and-complications-a-united-states-nationwide-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology